Cover Image
市場調查報告書

Lipocine Inc. : 產品平台分析

Lipocine Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226264
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Lipocine Inc. : 產品平台分析 Lipocine Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 29 Pages
簡介

Lipocine Inc.是開發並銷售增進男性及女性健康用產品之製藥公司。擁有男性睪固酮置換口服藥及候補藥,女性用預防早產的己酸羥孕酮口服藥。此外該公司更開發著改善調整胃腸最佳環境之難溶性藥劑吸收,基於脂質成分已取得專利之技術。

本報告提供Lipocine Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Lipocine Inc.的基本資料

  • Lipocine Inc.概要
  • 主要資訊
  • 企業資料

Lipocine Inc.:R&D概要

  • 主要的治療範圍

Lipocine Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Lipocine Inc.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式

Lipocine Inc.:藥物簡介

  • testosterone undecanoate
  • LPCN-1111
  • hydroxyprogesterone caproate

Lipocine Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Lipocine Inc.:最近的開發平台趨勢

Lipocine Inc.:暫停中的計劃

Lipocine Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07479CDB

Summary

Global Markets Direct's, 'Lipocine Inc. - Product Pipeline Review - 2015', provides an overview of the Lipocine Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Lipocine Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Lipocine Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Lipocine Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Lipocine Inc.'s pipeline products

Reasons to buy

  • Evaluate Lipocine Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Lipocine Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Lipocine Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Lipocine Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Lipocine Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Lipocine Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Lipocine Inc. Snapshot
    • Lipocine Inc. Overview
    • Key Information
    • Key Facts
  • Lipocine Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Lipocine Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Lipocine Inc. - Pipeline Products Glance
    • Lipocine Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Lipocine Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • Lipocine Inc. - Drug Profiles
    • testosterone undecanoate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LPCN-1111
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hydroxyprogesterone caproate
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Lipocine Inc. - Pipeline Analysis
    • Lipocine Inc. - Pipeline Products by Target
    • Lipocine Inc. - Pipeline Products by Route of Administration
    • Lipocine Inc. - Pipeline Products by Molecule Type
    • Lipocine Inc. - Pipeline Products by Mechanism of Action
  • Lipocine Inc. - Recent Pipeline Updates
  • Lipocine Inc. - Dormant Projects
  • Lipocine Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Lipocine Inc., Key Information
  • Lipocine Inc., Key Facts
  • Lipocine Inc. - Pipeline by Indication, 2015
  • Lipocine Inc. - Pipeline by Stage of Development, 2015
  • Lipocine Inc. - Monotherapy Products in Pipeline, 2015
  • Lipocine Inc. - Out-Licensed Products in Pipeline, 2015
  • Lipocine Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Lipocine Inc. - Phase III, 2015
  • Lipocine Inc. - Phase II, 2015
  • Lipocine Inc. - Phase I, 2015
  • Lipocine Inc. - Pipeline by Target, 2015
  • Lipocine Inc. - Pipeline by Route of Administration, 2015
  • Lipocine Inc. - Pipeline by Molecule Type, 2015
  • Lipocine Inc. - Pipeline Products by Mechanism of Action, 2015
  • Lipocine Inc. - Recent Pipeline Updates, 2015
  • Lipocine Inc. - Dormant Developmental Projects,2015

List of Figures

  • Lipocine Inc. - Pipeline by Top 10 Indication, 2015
  • Lipocine Inc. - Pipeline by Stage of Development, 2015
  • Lipocine Inc. - Monotherapy Products in Pipeline, 2015
  • Lipocine Inc. - Out-Licensed Products in Pipeline, 2015
  • Lipocine Inc. - Pipeline by Top 10 Target, 2015
  • Lipocine Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Lipocine Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Lipocine Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top